Drug Discovery and Development of Innovative Therapeutics INDIA
Mumbai, India - The conference bring together CEOs, therapeutic area experts, top scientists, R&D heads, investors, regulatory experts and business executives from India, the USA and Europe.
Attend this event and benefit from:
Strategies and Technologies to Accelerate from Discovery to POC
Explore Scientific Innovation from Indian Pharmas, Biotechs and Institutes
Build Your Portfolio in Metabolic Syndrome, Cancer, CNS, and Inflammation
Evaluate the Investment & Regulatory Landscape for Drug Development in India
Partnering System to Find Research Collaborators and New Molecules
IBC's 5th Annual Drug Discovery and Development of Innovative Therapeutics INDIA conference and exhibition has a completely new focus. The conference bring together CEOs, therapeutic area experts, top scientists, R&D heads, investors, regulatory experts and business executives from India, the USA and Europe to share new technologies, novel targets, scientific strategies, exciting molecules, portfolio-building approaches and partnering strategies in metabolic disease, cancer, CNS and inflammation. Find out how other companies approach drug discovery and development for the global marketplace in the following areas:
Developing an Innovative R&D Infrastructure, Therapeutic Area Expertise and Partnerships
The Critical Path: Biomarkers and Early POC Strategies to Improve Clinical Outcomes
Metabolic Disease: Diabetes, Translational Medicine and CADD Approaches
Oncology: Multiple Myeloma, Aurora Kinases and Human-Tissue Models
Inflammation: Systems Biology, Novel Targets and Inhibitors
You will also learn about multiple business models, and partnering strategies to help you identify potential collaborators, assets and investment opportunities. Drug discovery and development is a global endeavor conducted across many geographies, in multiple time zones and very often with multiple partners and collaborators. By attending this event you'll meet companies from around the world and hear concrete strategies to:
Expand your Global R&D Efforts and Partnering Network
Capitalize on India's Evolution from Drug Discovery Services to R&D Innovation and Therapeutics
Navigate the Funding, Investment and Regulatory Framework for Drug Development
Benefit from Risk-Share, Collaborative R&D and Licensing Deals to Build a Portfolio
Find New Molecules and Scientific Technologies
Why is Ranbaxy's Deal with Daiichi Sankyo Transformational?
Malviner Singh, Chief Executive Officer, Ranbaxy, India
Zydus' Drug Discovery Engine and Pipeline as an Example of India's Move to Innovation in Drug Development
Pankaj Patel, Managing Director, Zydus Cadila, India
Glenmark's NCE Infrastructure for Innovation and Success at International Partnerships
Glenn Saldanha, Managing Director and CEO, Glenmark Pharmaceuticals, India
Don't miss insights from the CEOs of Ranbaxy, Glenmark and Zydus Cadila, three of India's top R&D companies.
